Related Experiment Video
Updated: Sep 9, 2025

Substrate Generation for Endonucleases of CRISPR/Cas Systems
Published on: September 8, 2012
Diversity and abundance of ring nucleases in type III CRISPR-Cas loci
Ville Hoikkala1, Haotian Chi1, Sabine Grüschow1
1School of Biology, University of St Andrews, St Andrews, UK.
Abstract:
Most type III CRISPR-Cas systems facilitate immune responses against invading mobile genetic elements such as phages by generating cyclic oligoadenylates (cOAs). Downstream effectors activated by cOAs are typically non-specific proteins that induce damage to essential cellular components, thereby preventing phage epidemics. Owing to these toxic effects, it is crucial that the production and concentration of cOAs remain under tight regulatory control during infection-free periods or when deactivating the immune response after clearing an infection. Type III CRISPR loci often encode enzymes known as ring nucleases (RNs) that bind and degrade specific cOAs, while some effectors are auto-deactivating. Despite the discovery of several classes of RNs, a comprehensive bioinformatic analysis of type III CRISPR-Cas loci in this context is lacking. Here, we examined 38 742 prokaryotic genomes to provide a global overview of type III CRISPR loci, focusing on the known and predicted RNs. The candidate RNs Csx16 and Csx20 are confirmed as active enzymes, joining Crn1-3. Distributions and patterns of co-occurrence of RNs and associated effectors are explored, allowing the conclusion that a sizeable majority of type III CRISPR systems regulate cOA levels by degrading the signalling molecules, which has implications for cell fate following viral infection.This article is part of the discussion meeting issue 'The ecology and evolution of bacterial immune systems'.
Insights
Type III CRISPR-Cas systems use cyclic oligoadenylates (cOAs) for phage defense. This study confirms new ring nucleases (RNs) that degrade cOAs, revealing widespread regulation of these signaling molecules in bacterial immunity.
Area of Science:
- Microbiology
- Molecular Biology
- Genomics
Background:
- Type III CRISPR-Cas systems provide adaptive immunity against phages by producing cyclic oligoadenylates (cOAs).
- cOAs activate downstream effectors, but their uncontrolled production can be toxic to cells.
- Regulation of cOA levels is crucial for bacterial survival during and after infection.
Purpose of the Study:
- To conduct a comprehensive bioinformatic analysis of type III CRISPR-Cas loci globally.
- To identify and characterize ring nucleases (RNs) involved in cOA degradation within these systems.
- To explore the distribution and co-occurrence patterns of RNs and their associated effectors.
Main Methods:
- Analysis of 38,742 prokaryotic genomes.
- Bioinformatic identification of known and predicted ring nucleases (RNs) in type III CRISPR loci.
- Experimental confirmation of Csx16 and Csx20 as active RN enzymes.
Main Results:
- Identified and confirmed Csx16 and Csx20 as functional ring nucleases, alongside Crn1-3.
- Revealed widespread distribution and co-occurrence patterns of various RNs within type III CRISPR systems.
- Demonstrated that a majority of type III CRISPR systems employ RNs to degrade cOA signaling molecules.
Conclusions:
- A significant proportion of type III CRISPR systems utilize ring nucleases to regulate cyclic oligoadenylate levels.
- This regulation of cOA degradation is a key factor influencing bacterial cell fate following viral infections.
- The findings provide a global overview of RNs in type III CRISPR immunity and their ecological implications.
More Related Videos
11:35Selection-dependent and Independent Generation of CRISPR/Cas9-mediated Gene Knockouts in Mammalian Cells
Published on: June 16, 2017
10:07A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells
Published on: August 25, 2017
Related Concept Videos
CRISPR and crRNAs
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
Homologous Recombination
CRISPR
The Antiviral System of Bacteria and Archaea: CRISPR
CRISPR/Cas9 Genome Editing
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...